These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 35615352)

  • 1. Plant-Derived Toxin Inhibitors as Potential Candidates to Complement Antivenom Treatment in Snakebite Envenomations.
    Adrião AAX; Dos Santos AO; de Lima EJSP; Maciel JB; Paz WHP; da Silva FMA; Pucca MB; Moura-da-Silva AM; Monteiro WM; Sartim MA; Koolen HHF
    Front Immunol; 2022; 13():842576. PubMed ID: 35615352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological re-assessment of traditional medicinal plants-derived inhibitors as antidotes against snakebite envenoming: A critical review.
    Puzari U; Fernandes PA; Mukherjee AK
    J Ethnopharmacol; 2022 Jun; 292():115208. PubMed ID: 35314419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspective on the Therapeutics of Anti-Snake Venom.
    Gómez-Betancur I; Gogineni V; Salazar-Ospina A; León F
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31505752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects and Challenges of Developing Plant-Derived Snake Antivenin Natural Products: A Focus on West Africa.
    Yusuf AJ; Aleku GA; Bello UR; Liman DU
    ChemMedChem; 2021 Dec; 16(24):3635-3648. PubMed ID: 34585514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The State-of-the-Art of the Humoral Memory Response to Snakebites: Insights from the Yanomami Population.
    Jati SR; Dos Anjos Martins TA; Rocha AM; Melo-Dos-Santos G; de Oliveira IS; Ferreira IG; de Farias AS; Filardi ETM; Cerni FA; Sartim MA; de Almeida Gonçalves Sachett J; Monteiro WM; Pucca MB
    Toxins (Basel); 2023 Nov; 15(11):. PubMed ID: 37999502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodiversity as a source of bioactive compounds against snakebites.
    Guimaraes CL; Moreira-Dill LS; Fernandes RS; Costa TR; Hage-Melim LI; Marcussi S; Carvalho BM; da Silva SL; Zuliani JP; Fernandes CF; Calderon LA; Soares AM; Stabeli RG
    Curr Med Chem; 2014; 21(25):2952-79. PubMed ID: 24164199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antivenom for snakebite envenoming in Sri Lanka: the need for geographically specific antivenom and improved efficacy.
    Keyler DE; Gawarammana I; Gutiérrez JM; Sellahewa KH; McWhorter K; Malleappah R
    Toxicon; 2013 Jul; 69():90-7. PubMed ID: 23454626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of Brazilian native plant species used in the therapy for snakebites: A literature review.
    Konrath EL; Strauch I; Boeff DD; Arbo MD
    Toxicon; 2022 Oct; 217():17-40. PubMed ID: 35952835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concept of Big Four: Road map from snakebite epidemiology to antivenom efficacy.
    Gopal G; Muralidar S; Prakash D; Kamalakkannan A; Indhuprakash ST; Thirumalai D; Ambi SV
    Int J Biol Macromol; 2023 Jul; 242(Pt 1):124771. PubMed ID: 37169043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of the Proteomic Profiling of African Viperidae and Elapidae Snake Venoms and Their Antivenom Neutralisation.
    Offor BC; Muller B; Piater LA
    Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Ophidian Properties of Herbal Medicinal Plants: Could it be a Remedy for Snake Bite Envenomation?
    Panda S; Kumari L
    Curr Drug Discov Technol; 2019; 16(4):319-329. PubMed ID: 30019647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plants and Phytocompounds Active Against Bothrops Venoms.
    Jorge RJB; Martins RD; Araújo RM; da Silva MA; Monteiro HSA; Ximenes RM
    Curr Top Med Chem; 2019; 19(22):2003-2031. PubMed ID: 31340736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Presentations, Treatments, and Outcomes of Non-native Snake Envenomations in the United States Reported in the North American Snakebite Registry.
    Basse J; Ruha AM; Baumgartner K; Mullins ME; Greene S; Wax PM; Brent J; Campleman S; Schwarz ES;
    J Med Toxicol; 2023 Jan; 19(1):16-25. PubMed ID: 36175787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Snake antivenom: Challenges and alternate approaches.
    Alangode A; Rajan K; Nair BG
    Biochem Pharmacol; 2020 Nov; 181():114135. PubMed ID: 32628928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Snake antivenom production in Ecuador: Poor implementation, and an unplanned cessation leads to a call for a renaissance.
    Ortiz-Prado E; Yeager J; Andrade F; Schiavi-Guzman C; Abedrabbo-Figueroa P; Terán E; Gómez-Barreno L; Simbaña-Rivera K; Izquierdo-Condoy JS
    Toxicon; 2021 Oct; 202():90-97. PubMed ID: 34571098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the 'big four': Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies.
    Senji Laxme RR; Khochare S; de Souza HF; Ahuja B; Suranse V; Martin G; Whitaker R; Sunagar K
    PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007899. PubMed ID: 31805055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of phenolic acids in therapy against snakebites: A review.
    Ferreira SS; Silva DPD; Torres-Rêgo M; Silva-Júnior AAD; Fernandes-Pedrosa MF
    Toxicon; 2022 Mar; 208():1-12. PubMed ID: 34979199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venom neutralization by purified bioactive molecules: Synthetic peptide derivatives of the endogenous PLA(2) inhibitory protein PIP (a mini-review).
    Thwin MM; Samy RP; Satyanarayanajois SD; Gopalakrishnakone P
    Toxicon; 2010 Dec; 56(7):1275-83. PubMed ID: 20045432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims.
    Kini RM; Sidhu SS; Laustsen AH
    Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30551565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response towards snake venoms.
    León G; Sánchez L; Hernández A; Villalta M; Herrera M; Segura A; Estrada R; Gutiérrez JM
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):381-98. PubMed ID: 21824081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.